Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
1,164.46
+23.01 (+2.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings
May 10, 2021
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:
Via
Benzinga
Tesla, Qualcomm Plummet, Lead QQQ Sharply Lower Monday
May 10, 2021
The Nasdaq and companies in the broader technology sector were trading lower Monday amid profit-taking and overall weakness in the sector. Here&rsq...
Via
Benzinga
Earnings Scheduled For May 6, 2021
May 06, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Review Of Present Therapies For Covid-19
May 09, 2021
A summary of authorized drugs for Covid-19, those in development, and those that have failed.
Via
Talk Markets
Exposures
COVID-19
ARKK Stocks Breakdowns and Bounces
May 07, 2021
After struggling for most of the past couple of months, momentum and Tech stocks are broadly outperforming today.
Via
Talk Markets
Return On Capital Employed Overview: Regeneron Pharmaceuticals
May 07, 2021
Regeneron Pharmaceuticals (NASDAQ:REGN) posted a 4.65% decrease in earnings from Q4. Sales, however, increased by 4.37% over the previous quarter to $2.53 billion. Despite the...
Via
Benzinga
Regeneron Pharmaceuticals Inc (REGN) Q1 2021 Earnings Call Transcript
May 06, 2021
REGN earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Ocugen Shares Sink Despite OCU200 Being Comparable To Aflibercept In Reducing Neovascularization, Damage To Retina In Animal Study
May 06, 2021
Ocugen Inc (NASDAQ: OCGN) has announced the presentation of new preclinical data evaluating the efficacy of OCU200 in in-vitro and in-vivo models for ocular...
Via
Benzinga
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
May 07, 2021
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple...
Via
Benzinga
Looking Into Regeneron Pharmaceuticals's Return On Capital Employed
May 06, 2021
Looking Into Regeneron Pharmaceuticals's Return On Capital Employed Regeneron Pharmaceuticals (NASDAQ:REGN) posted a 4.65% decrease in earnings from Q4. Sales, however, increased...
Via
Benzinga
Why Regeneron's Q1 Results Looked Great Despite Its Revenue Miss
May 06, 2021
The big biotech delivered impressive revenue and earnings growth.
Via
The Motley Fool
Regeneron Reports Mixed Bag On Q1 Earnings; Eylea Franchise Boosts Revenue
May 06, 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned $9.89 per share for the first quarter, beating the $9.03 estimate. Revenue of $2.53 billion narrowly missed...
Via
Benzinga
Regeneron Pharmaceuticals: Q1 Earnings Insights
May 06, 2021
Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) decreased 0.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 49....
Via
Benzinga
Regeneron Earnings Top, Biotech Giant Edges Higher
May 06, 2021
Regeneron earnings comfortably beat Q1 views while sales were in line. The biotech giant edged higher before Thursday's open.
Via
Investor's Business Daily
Cathie Wood Loads Up More On Peloton, Skillz, Teladoc On The Dip
May 06, 2021
Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $48.53 million, in Skillz Inc (NYSE: SKLZ) on Wednesday. SKLZ shares closed 9% lower...
Via
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
India Gives Emergency Use Nod To Roche-Regeneron's COVID-19 Antibody Cocktail
May 05, 2021
Roche Holdings AG (OTCMKTS: RHHBY) has received Emergency Use Authorization in India for its investigational antibody cocktail (casirivimab and imdevimab) for...
Via
Benzinga
Exposures
COVID-19
Cathie Wood Loaded Up Further On Skillz On Earnings Day
May 05, 2021
Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $52.1 million, in Skillz Inc (NYSE: SKLZ) ahead of the mobile gaming company’s first-...
Via
Benzinga
Cathie Wood Loads Up More On Alibaba Rivals Pinduoduo, JD — Also Adds Skillz
May 04, 2021
Cathie Wood-led Ark Investment Management on Monday bought more shares of Pinduoduo Inc (NASDAQ: PDD) and JD.com Inc (NASDAQ: JD) — rivals to Alibaba Group Holding (...
Via
Benzinga
Novartis' Beovu Non-Inferior To Aflibercept In Phase 3 Diabetic Macular Edema Study
May 03, 2021
Novartis AG (NYSE: NVS) has reported that its Beovu (brolucizumab) drug met primary endpoints in Phase 3 KESTREL and KITE trials conducted...
Via
Benzinga
Biopharma Stocks Stall After Earnings, Lag Over 52 Weeks
May 01, 2021
It is hard to forecast with the current choppy setting in the biopharma sector, but assuming that the COVID-19 vaccinations are on track in the U.S., financial results should improve for most large-cap...
Via
Talk Markets
Exposures
COVID-19
Cathie Wood Piles Up Teladoc As Shares Slump On Q1 Miss, Also Adds More Tesla
April 29, 2021
Cathie Wood-led Ark Investment Management bought a total of 716,269 shares, worth about $122.38 million, in Teladoc Health Inc (NYSE: TDOC) on Thursday as the stock slumped after...
Via
Benzinga
Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran
April 28, 2021
Sanofi SA (NASDAQ: SNY) stock climbed after its Q1 earnings beat earnings expectations and stuck to its full-year guidance, as well as reported progress on its...
Via
Benzinga
Topics
Earnings
Exposures
Financial
Buy Alert: Regeneron Stock Is Headed Higher
April 28, 2021
A new delivery method for its COVID-19 treatment may offer a boost.
Via
The Motley Fool
Exposures
COVID-19
3 Cathie Wood Healthcare Stocks to Add to Your Portfolio
April 24, 2021
Despite generating lean capital gains on her holdings in the healthcare industry, Cathie Wood has maintained her positions because she expects genomics to emerge as the next big sector in 2021 that...
Via
Talk Markets
3 Top Coronavirus Stocks to Buy Right Now
April 24, 2021
Major gains may be on the horizon.
Via
The Motley Fool
Exposures
COVID-19
3 Cheap Cathie Wood Stocks to Buy Right Now
April 21, 2021
You don't need to pay a big premium for these buy-and-hold investments.
Via
The Motley Fool
Cathie Wood Loads Up Heavily On Debutant Uipath, Trims Tesla
April 22, 2021
Cathie Wood-led Ark Investment Management on Wednesday snapped up millions of shares of the New York-based software automation company UiPath Inc (NYSE: PATH) on the day that it...
Via
Benzinga
Will Regeneron's COVID Cocktail Win Be Short-Lived?
April 21, 2021
The biotech's antibody therapy continues to show promise. But there's considerable uncertainty about its long-term prospects.
Via
The Motley Fool
Exposures
COVID-19
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.